---
figid: PMC10820227__pharmaceuticals-17-00043-g007
pmcid: PMC10820227
image_filename: PMC10820227__pharmaceuticals-17-00043-g007.jpg
figure_link: /pmc/articles/PMC10820227/figure/F7/
number: Figure 7
figure_title: Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through
  the ESR2/PI3K/AKT Signalling Pathway
caption: ESR2/PI3K/AKT signalling pathway
article_title: Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through
  the ESR2/PI3K/AKT Signalling Pathway
citation: Fenglin Luo, et al. Pharmaceuticals (Basel). 2024 Jan;17(1).
year: '2024'
pub_date: 2024-1-
epub_date: '2023-12-27'
doi: 10.3390/ph17010043
journal_title: Pharmaceuticals
journa_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords:
- colorectal cancer
- Isoliquiritigenin
- network pharmacology
- ESR2
- PI3K/AKT pathway
---
